Biochemistry/Biology Alum Published
August 7, 2019
Anai Perez '17 was recently published in
The Science Daily. In a paper published in the July 31 issue of
Science Translational Medicine, researchers at Fred Hutchinson Cancer Research Center used CRISPR-Cas9 to edit long-lived blood stem cells to reverse the clinical symptoms observed with several blood disorders, including sickle cell disease and beta-thalassemia.
Read the article.